本页面由Tiger Trade Technology Pte. Ltd.提供服务

Oncternal Therapeutics, Inc.

0.5266
0.0000
成交量:- -
成交额:- -
市值:155.85万
市盈率:-0.05
高:0.5266
开:0.5266
低:0.5266
收:0.5266
52周最高:0.5266
52周最低:0.5266
股本:295.96万
流通股本:270.64万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-11.6916
每股收益(LYR):-13.4282
净资产收益率:-149.86%
总资产收益率:-74.11%
市净率:0.17
市盈率(LYR):-0.04

数据加载中...

2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/17

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/11/25

重要事件披露

Form 8-K - Current report
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report